ClinicalTrials.gg
RecruitingNCT07738263Updated Nov 4, 2026

Body-Based and Mind-Based Regulation in Overweight and Obese Women

An interventional study of Body-Based Regulation Program and Mind-Based Regulation Program in Overweight and/or Obesity, sponsored by Pamukkale University. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by Pamukkale University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Sep 2026; still recruiting 2 months later.
Updated Nov 4, 2026Now RecruitingSite recruiting status changedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 353 studies in Obesity with a site in Turkey — 73 open to participants now, 90 under way, 16 of them phase 3. Obesity · Turkey.

Planned enrollment
167th of 192
30 · median 64
Started
2026
with 59 others
No phase
161 of 353
29 open now
Primary completion
2027-05
later than 63 of 89 live
Registered
305th of 353
by date
Lead sponsor
9 of 353
Pamukkale University

Among the 353 studies in Obesity with a site in Turkey, this one is the 167th largest by planned enrollment of the 192 interventional ones that give a count, is one of 60 that started in 2026, is one of 161 with no phase, reaches primary completion later than 63 of the 89 other live ones, and was the 305th registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

73 of the 353 studies in Obesity with a site in Turkey are open now. Recruiting first, the newest first:

67 more — sign in →

All 73 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 18 Years to 60 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 353 studies in Obesity with a site in Turkey, or all of them as a file.
02

Study summary

This study will compare two regulation-based approaches in women with overweight or obesity. The first approach is a body-based regulation program including breathing awareness, body-awareness-based yoga practices, non-invasive manual auricular stimulation, and restorative relaxation. The second approach is a mind-based regulation program including structured psychoeducation and cognitive-emotional awareness activities focused on stress, emotions, automatic thoughts, and emotional eating.

Participants will be women aged 18 to 60 years with a body mass index between 27.0 and 39.9 kg/m². Eligible participants will be randomly assigned to one of the two intervention groups. Both programs will last 8 weeks.

The main aim of the study is to examine and compare the preliminary effects of these two approaches on heart rate variability, especially RMSSD, which is an indicator of cardiac vagal regulation. The study will also assess emotional eating, self-compassion, mindfulness, body measurements, body composition, adherence to the program, and possible adverse events. Assessments will be performed at baseline and after the 8-week intervention by an evaluator who is blinded to group allocation.

Read the detailed description

Overweight and obesity are associated not only with metabolic and physical health problems but also with changes in autonomic nervous system regulation, emotional eating, and psychological well-being. Reduced heart rate variability may reflect impaired cardiac vagal regulation and may be related to stress-related and emotion-related eating behaviors. Regulation-based approaches that target either body-to-mind or mind-to-body pathways may provide supportive strategies for improving autonomic and emotional regulation in women with overweight or obesity.

This study is designed as a two-arm, parallel-group, evaluator-blinded randomized trial. The study population will consist of women aged 18 to 60 years with overweight or obesity who apply to the Exercise and Obesity Unit of the Faculty of Physiotherapy and Rehabilitation, Pamukkale University. Participants will be randomized in a 1:1 ratio using BMI-category-stratified block randomization based on a computer-generated allocation sequence prepared by a researcher who is not involved in outcome assessment or intervention delivery. Allocation will be concealed until the baseline assessment is completed. The evaluator who performs baseline and post-intervention assessments will remain blinded to group allocation.

The Body-Based Regulation Group will receive an 8-week structured program delivered face-to-face by a physiotherapist. The program will include breathing awareness, body-awareness-based yoga practices, non-invasive manual auricular stimulation, and restorative relaxation. Sessions will be conducted twice weekly for 8 weeks, with each session lasting approximately 60 minutes. This intervention is intended to support autonomic and cardiac vagal regulation through body-based mechanisms.

The Mind-Based Regulation Group will receive an 8-week structured psychoeducation and cognitive-emotional awareness program. The program will focus on recognizing the relationships among stress, emotional states, automatic thoughts, and eating behavior; identifying triggers for emotional eating; developing more balanced cognitive responses; and creating alternative behavioral strategies for eating urges. Face-to-face structured sessions will be conducted in weeks 1, 4, and 8. In the remaining weeks, participants will receive standardized digital content and study forms and will attend short online meetings. The weekly module duration will be approximately 30 to 45 minutes. This intervention will not include yoga, breathing exercises, relaxation exercises, or other body-based practices.

Assessments will be conducted at baseline and after the 8-week intervention. Heart rate variability will be the primary physiological outcome. RR interval data will be recorded using a Polar H10 chest strap after a 10-minute quiet adaptation period, followed by a 5-minute resting recording. RMSSD will be the primary HRV parameter. If required according to distributional characteristics, RMSSD values will be analyzed after natural logarithmic transformation as lnRMSSD. Secondary HRV parameters will include HF, LF/HF, SDNN, and mean heart rate.

Patient-reported outcomes will include emotional eating, eating behavior, self-compassion, and mindfulness. Anthropometric measurements and body composition will be recorded as exploratory and descriptive outcomes. Adherence to the intervention, completion of home/module-related activities, and possible adverse events will also be monitored throughout the study.

The primary analysis will compare post-intervention RMSSD or lnRMSSD values between groups using an analysis of covariance model adjusted for baseline values. Secondary outcomes will be analyzed using similar baseline-adjusted models where appropriate. The study is planned to include 30 participants in total, with 15 participants in each group.

03

Conditions studied

  • Overweight and/or Obesity

Keywords

  • obesity
  • overweight
  • Heart Rate Variability
  • Emotional Eating
  • Body-Based Regulation
  • Mind-Based Regulation
  • Autonomic Nervous System
  • Psychological Well-Being
  • women
  • Randomized Controlled Trial
04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female participants.
  • Age between 18 and 60 years.
  • (BMI) between 27.0 and 39.9 kg/m².
  • No regular participation in yoga, meditation, breathing exercises, structured relaxation programs, or similar mind-body practices within the previous 3 months.
  • No initiation of a structured weight-loss program within the previous 3 months.
  • Able to attend weekly intervention sessions, modules, and study assessments.
  • Willing to refrain from starting any new exercise, yoga, meditation, diet, or weight-loss program during the study.
  • Able and willing to provide written .

Exclusion criteria

Exclusion Criteria:

  • ≥40 kg/m².
  • Uncontrolled hypertension or severe cardiovascular disease.
  • Cardiac arrhythmia, pacemaker, or other cardiac conditions that may affect heart rate variability (HRV).
  • Regular use of beta-blockers, antiarrhythmic agents, or other medications that substantially affect HRV (including medications affecting heart rate/rhythm, anticholinergic drugs, tricyclic antidepressants, and stimulant/sympathomimetic medications).
  • Neurological disease.
  • Uncontrolled thyroid disease or uncontrolled metabolic/endocrine disorders.
  • Pregnancy or breastfeeding.
  • History of bariatric surgery.
  • Initiation of weight-loss medication or GLP-1 receptor agonist therapy within the previous 6 months.
  • Current or clinically diagnosed anorexia nervosa, bulimia nervosa, binge eating disorder, or other eating disorders requiring active treatment (emotional eating alone is not an exclusion criterion).
  • Psychological or psychiatric conditions that would interfere with safe participation.
  • Diagnosed obstructive sleep apnea or untreated severe sleep disorders.
  • Regular tobacco or nicotine product use within the previous 3 months.
  • Musculoskeletal conditions preventing participation in the intervention.
  • Cardiopulmonary or orthopedic limitations that make exercise unsafe.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Body-Based Regulation Group

    Participants assigned to this arm will receive an 8-week body-based regulation program delivered by a physiotherapist. The intervention aims to improve body awareness, autonomic regulation, and emotional regulation. Outcome assessments will be conducted at baseline and at the end of the intervention.

    Behavioral: Body-Based Regulation Program

  • Experimental
    Mind-Based Regulation Group

    Participants assigned to this arm will receive an 8-week mind-based regulation program consisting of structured psychoeducation and cognitive-emotional awareness practices. Outcome assessments will be conducted at baseline and at the end of the intervention.

    Behavioral: Mind-Based Regulation Program

Interventions

  • BehavioralBody-Based Regulation Program

    Participants will receive an 8-week structured body-based regulation program administered by a physiotherapist. The program consists of 16 supervised face-to-face sessions (twice weekly, 60 minutes each) including breathing awareness exercises, body awareness-based yoga practices, non-invasive manual auricular stimulation, and restorative relaxation techniques. The intervention is designed to improve body awareness, autonomic nervous system regulation, and emotional regulation.

  • BehavioralMind-Based Regulation Program

    Participants will receive an 8-week structured psychoeducation and cognitive-emotional awareness program developed by a clinical psychologist. The intervention aims to improve awareness of the relationships among stress, emotions, automatic thoughts, and eating behavior, recognize emotional eating triggers, develop balanced cognitive responses, and strengthen adaptive coping strategies. The program includes face-to-face sessions during weeks 1, 4, and 8, standardized digital educational materials, weekly online follow-up meetings, and self-monitoring exercises. No yoga, breathing exercises, relaxation exercises, or body-based practices are included.

06

What researchers measure

Primary outcomes

  1. Heart Rate Variability (RMSSD)

    RMSSD (ms) will be derived from a 5-minute resting RR-interval recording obtained using a Polar H10 chest strap and analyzed using Kubios HRV software. If required based on distributional characteristics, RMSSD values will be natural-log transformed and analyzed as lnRMSSD.

    Time frame: Baseline and Week 8

Secondary outcomes

  1. High-Frequency Power (HF)

    Change in high-frequency (HF) power (ms²), an index of parasympathetic cardiac autonomic activity derived from heart rate variability recordings.

    Time frame: Baseline and Week 8

  2. Low Frequency/High Frequency Ratio (LF/HF Ratio)

    Change in the low frequency/high frequency (LF/HF) ratio derived from heart rate variability recordings.

    Time frame: Baseline and Week 8

  3. Standard Deviation of NN Intervals (SDNN)

    Change in the standard deviation of normal-to-normal intervals (SDNN, ms), a time-domain heart rate variability parameter reflecting overall autonomic variability.

    Time frame: Baseline and Week 8

  4. Mean Heart Rate

    Change in resting mean heart rate (beats per minute \[bpm\]) measured during the heart rate variability assessment.

    Time frame: Baseline and Week 8

  5. Eating Behavior (Dutch Eating Behavior Questionnaire, DEBQ)

    Eating behavior will be assessed using the validated Turkish version of the 33-item Dutch Eating Behavior Questionnaire (DEBQ). The questionnaire comprises three subscales assessing emotional eating, external eating, and restrained eating. Items are rated on a 5-point Likert scale ranging from "never" to "very often," with an additional "not applicable" response option where appropriate. Scores for the emotional eating, external eating, and restrained eating subscales will be calculated and analyzed separately according to the validated scoring instructions. Higher scores on each subscale indicate a greater tendency toward the corresponding eating behavior.

    Time frame: Baseline and Week 8

  6. Emotional Eating (Turkish Emotional Eating Scale)

    Emotional eating will be assessed using the 30-item Turkish Emotional Eating Scale. Each item is rated on a 5-point Likert scale ranging from 1 ("never") to 5 ("almost always"). The scale evaluates the tendency to eat in response to emotional states and related difficulties in controlling eating behavior. A total score is calculated by summing the item scores, with possible scores ranging from 30 to 150. Higher scores indicate a greater tendency toward emotional eating.

    Time frame: Baseline and Week 8

  7. Self-Compassion

    Self-compassion will be assessed using the validated Turkish version of the 24-item Self-Compassion Scale. The scale evaluates how individuals respond to themselves during difficult or distressing experiences. Items are rated on a 5-point Likert scale ranging from "almost never" to "almost always." Negatively worded items will be reverse-scored according to the validated scoring instructions. A total score will be calculated, with higher scores indicating greater self-compassion.

    Time frame: Baseline and Week 8

  8. Mindfulness

    Mindfulness will be assessed using the validated Turkish version of the 15-item Mindful Attention Awareness Scale (MAAS). The scale evaluates an individual's general tendency to attend to and remain aware of present-moment experiences in daily life. Items are rated on a 6-point Likert scale ranging from "almost always" to "almost never." A single overall score will be calculated according to the validated scoring instructions. Higher scores indicate greater mindful awareness.

    Time frame: Baseline and Week 8

  9. Protocol Adherence

    The percentage of prescribed intervention components completed will be recorded. In the Body-Based Regulation Group, adherence will be calculated based on attendance at the 16 supervised face-to-face sessions. In the Mind-Based Regulation Group, adherence will be calculated based on completion of weekly modules, digital content, brief online meetings, and study forms. Participants completing at least 80% of the prescribed intervention components will be classified as protocol completers.

    Time frame: Through Week 8

  10. Participants With Intervention-Related Adverse Events

    The number and type of symptoms, unexpected health problems, and adverse events occurring during or after the interventions and considered possibly related to the intervention will be recorded.

    Time frame: Through Week 8

Other outcomes

  1. Body Weight

    Change in body weight measured in kilograms using a calibrated digital scale

    Time frame: Baseline and Week 8

  2. Body Mass Index (BMI)

    Change in body mass index (kg/m²) calculated as weight in kilograms divided by height in meters squared.

    Time frame: Baseline and Week 8

  3. Waist Circumference

    Change in waist circumference (cm) measured using a non-stretch measuring tape.

    Time frame: Baseline and Week 8

  4. Hip Circumference

    Change in hip circumference (cm) measured using a non-stretch measuring tape.

    Time frame: Baseline and Week 8

  5. Waist-to-Hip Ratio

    Change in waist-to-hip ratio calculated from waist and hip circumference measurements.

    Time frame: Baseline and Week 8

  6. Body Fat Percentage

    Change in body fat percentage (%) measured using bioelectrical impedance analysis (Tanita BC-418).

    Time frame: Baseline and Week 8

  7. Muscle Mass

    Change in muscle mass (kg) measured using bioelectrical impedance analysis (Tanita BC-418).

    Time frame: Baseline and Week 8

  8. Fat-Free Mass

    Change in fat-free mass (kg) measured using bioelectrical impedance analysis (Tanita BC-418).

    Time frame: Baseline and Week 8

07

Study locations

1 of 1 sites recruiting
  • Pamukkale University, Faculty of Physiotherapy and Rehabilitation, Exercise and Obesity Unit
    Denizli, Turkey (Türkiye)
    Recruiting
    • Raziye Şavkın, Assoc. Prof. · Contactrkirkoluk@pau.edu.tr · +902582964253
    • Duygu Mert, PT · Principal investigator
    • Burak Bulcu, Licensed Clinical Psychologist · Sub investigator
    • Mehtap Mert, PT, MSc · Sub investigator
    • Ummuhan Baş Aslan, Prof · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2026 (actual). Primary completion is estimated for May 2027, 8 months after the start.

Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 8 months is below that.

Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 6, 2026
First posted
Jul 31, 2026
StartActual
Sep 12, 2026
Primary completionEst.
May 2027
CompletionEst.
May 2027
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 4, 2026
Sites
Pamukkale University, Faculty of Physiotherapy and Rehabilitation, Exercise and Obesity Unit is now Recruiting
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    Not yet recruiting→Recruiting
    Pamukkale University, Faculty of Physiotherapy and Rehabilitation, Exercise and Obesity Unit is now Recruiting
    + 2 other changes: verification date and date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07738263
Responsible party
Raziye Şavkın (Assoc. Prof., Pamukkale University) — Principal investigator
First posted
Jul 31, 2026
Start date
Sep 12, 2026
Primary completion
May 2027 (estimated)
Completion
May 2027 (estimated)
Last update
Nov 4, 2026

Study contacts

Raziye ŞAVKIN, Assoc. Prof.
Contact
rkirkoluk@pau.edu.tr
+902582964253
Raziye ŞAVKIN, PhD
study chair · Pamukkale University, Faculty of Physiotherapy and Rehabilitation

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion